Guidant Global’s APAC Director Doug Edmonds speaks to our strategic partner George Wang, CEO of Talentkey about the state of China's contingent workforce labour market following the coronavirus outbreak.
#EndureTransform is designed to keep you up to date with the latest global MSP market insights during these turbulent times. In this ongoing video series, we share valuable insights from Guidant Global leaders and industry experts so that we can support you and your business in addressing current market challenges and better prepare you for future growth and transformation.
Guidant Global Chief Operating Officer, Brian Salkowski gives an insight into how an MSP can support employers with the rapid onboarding (or sadly off-boarding) of contingent workers at scale during the coronavirus pandemic.
Guidant Global's VP, Sales and Channel Partner, Andrew Erlichman speaks to our strategic partner Rory Spanier, Client Partner at Toptal about how to access their elite, on-demand talent network and build a high performing culture remotely.
Guidant Global APAC Director Doug Edmonds speaks to Kapil Sharma, CSO at Collabera Inc. about the post-COVID-19 future for the outsourcing market in the Asia Pacific region.
Impellam Group's APAC CEO Mark Coyle speaks to Doug Edmonds in our latest #EndureTransform video on the current impact and recovery of contingent workforce programs in Australia.
Guidant Global’s SVP, Client Solutions, Robin Sanders is joined by Dr Pamela Cohen, President of WerkLabs, to talk about how working parents, particularly mothers, have been adversely impacted by the pandemic and what employers should do to support this group of employees and improve their working experience.
Guidant’s APAC Director, Doug Edmounds is joined by Peter Hader, Senior Account Director at Coupa, discussing Coupa’s insight into impacts COVID-19 is having on spend behaviours based on findings from anonymised spend data totalling $1.5 Trillion, and why companies are turning to the contingent workforce to navigate a world changed by COVID-19.